Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 29.76
+0.41 (1.40%)
Sep 30, 2026, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 9.41 billion as of October 2, 2026. Its market cap has decreased by -27.94% in one year.
Market Cap
9.41B
Enterprise Value
11.29B
Revenue
2.03B
Ranking
n/a
PE Ratio
39.50
Stock Price
29.76
ChartMarket Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 9.41B, a decrease of -43.07%. That is a compound annual growth rate of -9.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.41B | -21.06% |
| Dec 31, 2025 | 11.92B | 4.42% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
| May 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 10.50B |
| Staidson (Beijing) BioPharmaceuticals | 9.77B |
| Jiangxi Fushine Pharmaceutical | 9.62B |
| Pacific Shuanglin Bio-pharmacy | 9.44B |
| Chongqing Genrix Biopharmaceutical | 9.28B |
| Chengdu Easton Biopharmaceuticals | 8.88B |
| Vcanbio Cell & Gene Engineering Corp., | 8.85B |
| Bio-Thera Solutions | 8.71B |